339P AI-CROSS: Can artificial intelligence predict response to neoadjuvant chemoradiotherapy (CROSS) in gastro-oesophageal junction adenocarcinoma? A prospective randomized trial
339P AI-CROSS: Can artificial intelligence predict response to neoadjuvant chemoradiotherapy (CROSS) in gastro-oesophageal junction adenocarcinoma? A prospective randomized trial. // ESMO Real World Data and Digital Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949820126004662?dgcid=rss_sd_all
339P AI-CROSS: Can artificial intelligence predict response to neoadjuvant chemoradiotherapy (CROSS) in gastro-oesophageal junction adenocarcinoma? A prospective randomized trial. ESMO Real World Data and Digital Oncology. https://www.sciencedirect.com/science/article/pii/S2949820126004662?dgcid=rss_sd_all
“339P AI-CROSS: Can artificial intelligence predict response to neoadjuvant chemoradiotherapy (CROSS) in gastro-oesophageal junction adenocarcinoma? A prospective randomized trial.” ESMO Real World Data and Digital Oncology.
@article{article98943,
title = {339P AI-CROSS: Can artificial intelligence predict response to neoadjuvant chemoradiotherapy (CROSS) in gastro-oesophageal junction adenocarcinoma? A prospective randomized trial},
journal = {ESMO Real World Data and Digital Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949820126004662?dgcid=rss_sd_all}
}